Copenhagen Bioengineering ApS
CVR 37640549 · Private limited company (ApS) · Active · Low risk
Copenhagen Bioengineering ApS is a Private limited company (ApS), founded on , based in Hårlev. The company is registered in the industry leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 10 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 809k and a net result of DKK -210k. CEO: Marco Falkenløve Kaaber.
Bankruptcy risk for Copenhagen Bioengineering ApS
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 37640549
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (10 years)
- Address
- Tingvej 1
4652 Hårlev - Municipality
- Stevns
- Industry
- Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker (774000)
Bankruptcies in the industry: Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver i.a.n. - Share capital
- DKK 50k
- Auditor
- Dansk Revision Næstved Godkendt Revisionsaktieselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 4 of 10 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 98.0% |
| Current ratio | 4,308% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK -91k | DKK 137k |
| Net profit | DKK -210k | DKK 27k |
| Equity | DKK 809k | DKK 1.0m |
| Total assets | DKK 825k | DKK 1.0m |
| Cash | DKK 628k | – |
| Short-term debt | DKK 16k | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Dansk Revision Næstved Godkendt Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 173 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 1 Jan 2023 – 31 Dec 2023 | 184 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 199 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 194 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 180 | ||
| 1 Jan 2019 – 31 Dec 2019 | 241 | Late | |
| 1 Jan 2018 – 31 Dec 2018 | 175 | ||
| 1 Jan 2017 – 31 Dec 2017 | 64 | ||
| 26 Apr 2016 – 31 Dec 2016 | 172 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Marco Falkenløve Kaaber | Current | |
| CEO | Helge Anker Andreasen | ||
| Board | Niels Juul Jensen | Current | |
| Board | Helge Anker Andreasen | ||
| Owner (20%) | M.F. Kaaber Holding ApS | Current | |
| Owner (25%) | Strukturforsyningen ApS | Current | |
| Owner (25%) | Holtug Holding ApS | Current | |
| Owner (25%) | P.F. Kaaber Holding ApS | Current | |
| Owner (10%) | Strukturforsyningen ApS | ||
| Owner (10%) | INNOCHEM ApS | ||
| Owner (10%) | Holtug Holding ApS | ||
| Owner (10%) | M.F. Kaaber Holding ApS | ||
| Owner (10%) | P.F. Kaaber Holding ApS | ||
| Owner (10%) | E90 Holding ApS | ||
| Owner (10%) | H. Andreasen Holding ApS | ||
| Owner (15%) | Strukturforsyningen ApS | ||
| Owner (15%) | INNOCHEM ApS | ||
| Owner (15%) | P.F. Kaaber Holding ApS | ||
| Owner (15%) | Holtug Holding ApS | ||
| Owner (15%) | M.F. Kaaber Holding ApS | ||
| Owner (20%) | Strukturforsyningen ApS | ||
| Owner (20%) | Holtug Holding ApS | ||
| Owner (20%) | P.F. Kaaber Holding ApS | ||
| Auditor | bp-revision v/Bent Pedersen | ||
| Auditor | Barrett revisionsanpartsselskab | ||
| Auditor | Dansk Revision Næstved Godkendt Revisionsaktieselskab | ||
| Founder | Strukturforsyningen ApS | Current | |
| Founder | INNOCHEM ApS | Current | |
| Founder | Holtug Holding ApS | Current | |
| Founder | M.F. Kaaber Holding ApS | Current | |
| Founder | P.F. Kaaber Holding ApS | Current | |
| Founder | E90 Holding ApS | Current | |
| Founder | H. Andreasen Holding ApS | Current |
The CEOs' other companies
Marco Falkenløve Kaaber – 2 other companies
- Copenhagen Biorefinery ApS Active
- M.F. Kaaber Holding ApS Active
Helge Anker Andreasen – 8 other companies, of which 1 bankrupt
- FÆLLED FESTIVAL ApS Bankrupt 5 Nov 1991
- Copenhagen Biorefinery ApS Active
- H. Andreasen Holding ApS Active
- LYNGBY-TAARBÆK AFFALD A/S Active
- LYNGBY-TAARBÆK FORSYNING A/S Active
- LYNGBY-TAARBÆK FORSYNING HOLDING A/S Active
- LYNGBY-TAARBÆK SPILDEVAND A/S Active
- LYNGBY-TAARBÆK VAND A/S Active
Address history (0 moves)
| Tingvej 1, 4652 Hårlev |
Other companies at the same address
- Copenhagen Biorefinery ApS Active
Similar companies in Stevns
Questions and answers about Copenhagen Bioengineering ApS
Has Copenhagen Bioengineering ApS gone bankrupt?
No, Copenhagen Bioengineering ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Copenhagen Bioengineering ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the CEO of Copenhagen Bioengineering ApS?
Marco Falkenløve Kaaber is the CEO of Copenhagen Bioengineering ApS.
Who is the auditor of Copenhagen Bioengineering ApS?
Copenhagen Bioengineering ApS most recently used Dansk Revision Næstved Godkendt Revisionsaktieselskab.
When was Copenhagen Bioengineering ApS founded?
Copenhagen Bioengineering ApS was founded on 26 April 2016.
What is the equity of Copenhagen Bioengineering ApS?
Equity was DKK 809k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.